Globally, most cancer patients die not because they don’t have access to newer drugs, but because they don’t have access to even basic treatments. Cancer groundshot aims to improve treatment access.
The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet, better design could help fulfill its promise.
Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.
Artificial cells on tiny microfluidic chips can provide early insight into how new cancer drugs behave in cells, and why certain kinds of cancer are more resistant to chemotherapy treatment.
Neutrons are useful in research and medicine. A proposed neutron production facility could help further Canadian research and provide a source of neutrons for medical purposes.
Low-dose CT scans can detect lung cancer in smokers and former smokers at an early and sometimes treatable stage. Why are so few smokers and former smokers getting them?
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO
Pancreatic cancer currently has one of the least optimistic prognosis, with just 5% of patients surviving five years after diagnosis. A recent study opens a door to hope.